buildlife glp-1 1LIFESCIENCE PRO Probiotic Blend+ 60 Veggie caps 1LifeScience GLP-1 Pro Weight Management

With an increasing number of similar GLP-1 drugs now being used in clinical practice, for conditions ranging from type 2 diabetes and obesity to kidney disease, our findings highlight the potential for these existing drugs to be repurposed to treat the risk of no-reflow in heart attack patients, offering a potentially life-saving solution, said University College London Professor David Atwell

This may lead to a serious condition where bone tissue dies due to a lack of blood supply (osteonecrosis)

Clinical trials showed an average weight loss of 11.2% over 16 months at the highest dose

Many patients experience improved insulin sensitivity, more stable blood sugar levels, and better metabolic markers across the board